Here's the latest research and science on brain aging.  What's new and what actually works including Alzheimer’s drugs, blood tests, diet, exercise, sleep, and lifestyle to protect cognition.

What’s truly new (and worth your attention)

1) Disease-modifying Alzheimer’s drugs have arrived.
Two anti-amyloid monoclonal antibodies—lecanemab (Leqembi) and donanemab (Kisunla)—now have full FDA approvals for early Alzheimer’s disease after phase 3 trials showed slowed clinical decline versus placebo. These are not cures, and careful MRI monitoring for ARIA (brain swelling/bleeding) is required, but they mark a real shift from symptom control to disease modification. Reuters+3U.S. Food and Drug Administration+3New England Journal of Medicine+3

2) A practical blood test is entering clinics.
High-accuracy plasma p-tau217 assays can identify Alzheimer’s pathology with performance approaching CSF/PET in many settings, and recent work suggests a two-cutoff approach improves real-world use. These tests are not perfect screening tools yet, but they are dramatically lowering barriers to earlier diagnosis and trial access. JAMA Network+2JAMA Network+2

3) Treating hearing loss protects thinking—if you’re at higher risk.
The ACHIEVE randomized trial found that providing hearing aids and counseling slowed cognitive decline over 3 years in older adults at higher dementia risk (no benefit in lower-risk groups). If you or a loved one reports hearing trouble, get tested and treat it. PubMed+1

4) Multidomain lifestyle programs remain the best “whole-life” bet.
The original FINGER trial and its global offshoots (World-Wide FINGERS) support combined nutrition, exercise, vascular risk control, and cognitive training to maintain cognition in at-risk older adults. Ongoing trials (e.g., FINGER-NL) are fine-tuning who benefits most. ScienceDirect+1

5) Everyday prevention levers are clearer.
Updated Lancet Commission guidance now estimates that tackling 14 modifiable risk factors (including hearing and vision loss, midlife hypertension and high LDL, inactivity, diabetes, depression, smoking, heavy alcohol use, social isolation, air pollution, and head injury) could prevent or delay up to ~45% of dementia cases. The Lancet+1

Diet & supplements with the best evidence

• MIND or Mediterranean-style eating: Emphasize leafy greens, berries, nuts, legumes, fish, olive oil, and whole grains while minimizing ultra-processed foods. RCT evidence for the MIND diet is mixed but promising; observational studies generally show slower decline. PMC+1

• Ultra-processed foods (UPFs): Higher UPF intake is linked to faster cognitive decline; make these foods a rare exception rather than a staple. JAMA Network+1

• Multivitamin/mineral (MVM): The COSMOS-Mind program found small but statistically significant cognitive benefits for daily MVM; cocoa flavanol supplements did not improve cognition overall. Consider an inexpensive MVM if your diet is inconsistent, but prioritize food first. PMC+2PubMed+2

Exercise & everyday habits that move the needle

• Strength + aerobic training: Resistance training improves executive function in older women; combined aerobic/resistance programs (and sometimes with cognitive training) benefit people with MCI. Aim for at least 150 minutes/week of moderate aerobic activity plus 2+ days/week of strength work. PubMed+1

• Blood pressure control: Intensive BP control reduced risk of mild cognitive impairment and the combined outcome of MCI or dementia in SPRINT-MIND. Work with your clinician to individualize targets. PubMed

• Sleep: Poor sleep and insomnia correlate with higher dementia risk; extended sleep (>9h) also associates with risk in some analyses. Prioritize sleep quality and treat sleep disorders (e.g., apnea). AJP Monline+1

• Hearing & vision: Correct hearing loss (ACHIEVE) and vision problems (now recognized risk factors). PubMed+1

• Social/cognitive engagement: Remains a core pillar across guidelines (WHO, Lancet). World Health Organization

The riskiest habits—and what to swap in

• Heavy alcohol use (and possibly any regular use): New Mendelian-randomization analyses and diverse cohort work suggest no safe level for brain health; less is better. If you drink, keep it minimal and non-daily. The Lancet+1

• Ultra-processed foods: Linked with faster decline—replace with whole, minimally processed meals. JAMA Network

• Smoking, physical inactivity, unmanaged vascular risks, social isolation, untreated hearing/vision loss: All increase dementia risk; address systematically. The Lancet

10-Step Plan to Amp Up Brain Health (Starting This Week)

1. Check your numbers. Ask your clinician to review BP, LDL-C, A1c, BMI/waist, and discuss personalized targets. Better vascular control = better brain outcomes. PubMed

2. Upgrade your hearing and vision. Schedule screenings; use hearing aids and proper eyewear if needed. PubMed+1

3. Move most days; lift twice weekly. Accumulate 150 minutes/week of brisk walking or cycling and add 2 strength sessions focused on legs/hips/back/core. PubMed

4. Eat MIND-style. Build meals around greens, berries, beans, fish, nuts, olive oil, whole grains; limit UPFs. PMC+1

5. Audit alcohol. Zero is safest for brain health; if you do drink, keep it rare and light. The Lancet

6. Prioritize sleep. Aim for 7–8 hours; treat apnea and insomnia; keep regular sleep/wake times. AJP Monline

7. Stay socially and cognitively active. Join a class, volunteer, play music, learn a language—mix novelty with repetition. World Health Organization

8. Consider a daily multivitamin. Expect modest benefits at best; it complements (not replaces) food. PMC

9. Protect your head and lungs. Wear helmets for risky activities; reduce exposure to air pollution when possible. The Lancet

10. Revisit medications and supplements. Review with your clinician to avoid anticholinergic burden and interactions; personalize choices (e.g., omega-3s, B12 if deficient). (Guideline context.) World Health Organization

Where to go deeper (top references & resources)

• FDA on donanemab (Kisunla) & lecanemab (Leqembi). U.S. Food and Drug Administration+1

• NEJM lecanemab phase 3 (Clarity AD). New England Journal of Medicine

• Lancet/Alzheimer’s & Dementia: ACHIEVE trial; FINGER & World-Wide FINGERS. PubMed+1

• JAMA/Alzheimer’s journals on p-tau217 blood tests. JAMA Network+1

• WHO & Lancet Commission prevention guidelines. World Health Organization+1

• COSMOS-Mind multivitamin findings. PMC

Why this matters for aging well

Cognitive health underpins your ability to manage medications, finances, driving, social ties, and daily routines that support independent living, assisted living success, and aging in place. The most powerful approach is cumulative: combine risk-factor control (hearing/vision/BP/LDL/sleep) with movement, high-quality nutrition, and social/cognitive engagement—then layer in medical advances when appropriate. The Lancet

Legal disclaimer

This article is for educational purposes only and is not a substitute for personalized medical advice, diagnosis, or treatment. Always talk with your licensed healthcare provider about your specific health situation, medications, and risk factors.

​​​​